PharmaVoice Logo

Healthcare Leaders Hub

Jeff Miglicco on Digital Compliance & Healthcare Waste Management: PureWay’s Vision for Safer, Sustainable Operations

PharmaShots

Jeff Miglicco on Digital Compliance & Healthcare Waste Management: PureWay’s Vision for Safer, Sustainable Operations

Shots:  Saurabh: PureWay Compliance focuses on making OSHA compliance and healthcare waste management simpler and more accessible. How is digital innovation helping PureWay simplify traditionally complex compliance processes for healthcare organizations?  Jeff: Digital innovation is really about taking compliance activities that have traditionally been manual, fragmented, and difficult to manage and making them much easier… The post Jeff Miglicco on Digital Compliance & Healthcare Waste Management: PureWay’s Vision for Safer, Sustainable Operations appeared first on PharmaShots.

Read Full Article
AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo 

Pharma Tech

AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo 

Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective mechanism.

Read Full Article
Oral solid dose at a turning point: Scaling for the next generation of therapies

Pharma Tech

Oral solid dose at a turning point: Scaling for the next generation of therapies

From patient-centric designs and sustainable changes to component shortages, anti-counterfeiting, and low-volume production, sponsors of OSD products are navigating a number of packaging trends and challenges.

Read Full Article
Novo inks $1.33bn long-lasting injectable pact with Sweden-based Nanexa

Pharma Tech

Novo inks $1.33bn long-lasting injectable pact with Sweden-based Nanexa

Novo has meanwhile been busy bolstering its pipeline amid a target to launch more than five multi-blockbusters by 2030.

Read Full Article
Daiichi Sankyo, MSD withdraw cancer drug application

Pharma Tech

Daiichi Sankyo, MSD withdraw cancer drug application

Daiichi Sankyo and Merck & Co (MSD) have voluntarily withdrawn their biologics license application (BLA) for ifinatamab deruxtecan, aimed at treating adult patients with extensive-stage small cell lung cancer (ES-SCLC).

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Sep 28, 2026, 1:30 PM

Jeff Miglicco on Digital Compliance & Healthcare Waste Management: PureWay’s Vision for Safer, Sustainable Operations

Shots:  Saurabh: PureWay Compliance focuses on making OSHA compliance and healthcare waste management simpler and more accessible. How is digital innovation helping PureWay simplify traditionally complex compliance processes for healthcare organizations?  Jeff: Digital innovation is really about taking compliance activities that have traditionally been manual, fragmented, and difficult to manage and making them much easier… The post Jeff Miglicco on Digital Compliance & Healthcare Waste Management: PureWay’s Vision for Safer, Sustainable Operations appeared first on PharmaShots.

PharmaShots

Sep 28, 2026, 12:30 PM

Merck and SciBrunch Sign ~$2.13B Exclusive Global License Agreement for SPR2015

Shots: Ref: Businesswire   |   Image:  Merck & SciBrunch  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Merck and SciBrunch Sign ~$2.13B Exclusive Global License Agreement for SPR2015 appeared first on PharmaShots.

Pharma Tech

Sep 28, 2026, 12:12 PM

AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo 

Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective mechanism.

PharmaShots

Sep 28, 2026, 11:30 AM

QIAGEN Receives the US FDA Clearance for QIAstat-Dx BCID GN Plus AMR Panel

Shots: Ref: Businesswire   |   Image:  QIAGEN  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post QIAGEN Receives the US FDA Clearance for QIAstat-Dx BCID GN Plus AMR Panel appeared first on PharmaShots.

PharmaShots

Sep 28, 2026, 10:53 AM

Wholesale Distribution Is Reshaping Aesthetic Medicine Procurement

Wholesale distribution has quietly become one of the more consequential shifts in how aesthetic medicine practices source injectables, and it’s changing procurement decisions industry-wide. The aesthetic injectables market has grown quickly over the past several years, but the more interesting shift may be happening upstream, in how clinics actually source the products they use. Distributors… The post Wholesale Distribution Is Reshaping Aesthetic Medicine Procurement appeared first on PharmaShots.

Pharma Tech

Sep 28, 2026, 10:30 AM

Oral solid dose at a turning point: Scaling for the next generation of therapies

From patient-centric designs and sustainable changes to component shortages, anti-counterfeiting, and low-volume production, sponsors of OSD products are navigating a number of packaging trends and challenges.

News

Latest industry coverage

Google News

Sep 28, 2026, 9:17 PM

Teva Pharmaceutical Industries Gains FDA Nod for Degevma Biosimi - GuruFocus

Teva Pharmaceutical Industries Gains FDA Nod for Degevma Biosimi  GuruFocus

Google News

Sep 28, 2026, 9:05 PM

Beyond OEB5: Is OEB6 really the next standard for high-potency pharma? - Pharmaceutical Technology

Beyond OEB5: Is OEB6 really the next standard for high-potency pharma?  Pharmaceutical Technology

Google News

Sep 28, 2026, 8:46 PM

Merck discontinues a crucial antibiotic despite concerns over superbug resistance - STAT

Merck discontinues a crucial antibiotic despite concerns over superbug resistance  STAT

Google News

Sep 28, 2026, 8:09 PM

Circle Pharma Makes Two Executive Team Announcements - Contract Pharma

Circle Pharma Makes Two Executive Team Announcements  Contract Pharma

Google News

Sep 28, 2026, 8:07 PM

The Long Game of Brain Tumor Innovation: Servier at ABTA 2026 – Servier Pharmaceuticals - Oncodaily

The Long Game of Brain Tumor Innovation: Servier at ABTA 2026 – Servier Pharmaceuticals  Oncodaily

Google News

Sep 28, 2026, 8:07 PM

How Singapore is a hub for global biotech and pharmaceutical companies to access growth - Singapore Economic Development Board (EDB)

How Singapore is a hub for global biotech and pharmaceutical companies to access growth  Singapore Economic Development Board (EDB)

Google News

Sep 28, 2026, 7:42 PM

New EU medicine rules promise access boost but raise industry tensions - The Brussels Times

New EU medicine rules promise access boost but raise industry tensions  The Brussels Times

Google News

Sep 28, 2026, 6:56 PM

Franklin Biotechnology Discovery Fund Q2 2026 Commentary - Seeking Alpha

Franklin Biotechnology Discovery Fund Q2 2026 Commentary  Seeking Alpha

Google News

Sep 28, 2026, 6:36 PM

India among 20 countries exempted from US tariffs on certain speciality drugs - CNBC TV18

India among 20 countries exempted from US tariffs on certain speciality drugs  CNBC TV18

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer